Indian Startups, Fujitsu, and Singapore Drive New AI Healthcare Moves
- Reveal HealthTech (India) raises $7.2M Series A to expand AI healthcare solutions into the US.
- Singapore approves AI-powered LungVision platform for earlier, more accurate lung cancer detection.
- Fujitsu (Japan) launches NVIDIA-backed AI agent platform, while HealthPresso (India) expands HUMETA to US & UAE.
Bengaluru-based healthtech startup Reveal HealthTech has raised $7.2 million in Series A funding led Leo Capital, with Sanos Capital also participating. Founded in 2023, the company develops AI-driven systems to enhance patient experiences, streamline clinician workflows, and optimize hospital operations. Its flagship multimodal AI solutions feature smart agents for workflow automation. The fresh capital will go toward strengthening sales, expanding global presence especially in the US and advancing AI capabilities. The company also announced plans to join the Cipher Collective, a US-based consortium of healthcare AI innovators.
US-based Body Vision Medical has received pre-market approval in Singapore for its AI-powered lung cancer imaging platform LungVision, following clearance from the Health Sciences Authority.
The system provides near real-time 3D imaging to support early and accurate detection of pulmonary nodules, enabling more precise bronchoscopic biopsies. Given that most lung cancers in Singapore are diagnosed at late stages, LungVision could help improve survival outcomes. Local distribution will be managed by Scanmed Technology.
Fujitsu has unveiled a new AI agent platform tailored for healthcare in Japan. Built with support from NVIDIA, the platform includes an orchestrator agent that coordinates multiple specialized healthcare AI agents for tasks like data structuring, interoperability monitoring, and workflow automation. The system also allows integration of third-party AI agents. Fujitsu is now seeking collaborations to validate the platform and expand industry-specific applications.
Indian company HealthPresso TechnoMedia has rolled out its AI-powered healthcare content platform HUMETA in the United States and United Arab Emirates. Built on proprietary retrieval-augmented generation (RAG) architecture and trained on over 3.5 million verified medical datasets, HUMETA generates multilingual, multi-format medical content ranging from continuing medical education and discharge summaries to patient explainers and scientific publications. Designed to help doctors produce accurate, regulation-compliant material, the platform is supported by a $2 million pre-seed funding round to fuel expansion.
